FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057910285> ?p ?o ?g. }

• W2057910285 endingPage "233" @default.
• W2057910285 startingPage "228" @default.
• W2057910285 abstract "Diabetes mellitus is associated with an increased risk of cardiovascular disease. Endothelial dysfunction (i.e. decreased endothelium-dependent vasorelaxation) plays a key role in the pathogenesis of diabetic vascular disease. The present study was undertaken to determine whether diabetes induced by streptozotocin alters mesenteric responses to vasodilators and, if so, to study the acute in vitro effects of lovastatin and chelerythrine. Endothelial function was assessed in constantly perfused preparation removed from rats, 12 weeks after treatment with either saline or streptozotocin (45 mg/kg, intraperitoneally). In pre-contracted mesenteric beds (with 100 microM phenylephrine) removed from diabetic rats, the concentration response curve to acetylcholine, but not to sodium nitroprusside, was significantly reduced. Perfusion with lovastatin (10 microM for 20 min) or chelerythrine (1 microM for 20 min) significantly improved the acetylcholine-mediated relaxation in preparations removed from diabetic but not control rats. Pre-incubation of tissue with N(G)-nitro-L-argenine methyl ester hydrochloride (10 microM for 20 min) inhibited the beneficial effect of lovastatin but not chelerythrine. Pre-treatment of tissue with indomethacin (10 microM for 20 min) did not modify the effects of lovastatin or chelerythrine on acetylcholine responses. The present results demonstrate that endothelial dysfunction induced by diabetes (in a resistant vasculature, such as rat mesenteric bed) may be improved by an acute exposure to either lovastatin or chelerythrine. Furthermore, our results suggest that the beneficial effect of lovastatin is mediated via the nitric oxide pathway." @default.
• W2057910285 created "2016-06-24" @default.
• W2057910285 creator A5002206863 @default.
• W2057910285 creator A5003379401 @default.
• W2057910285 creator A5010069897 @default.
• W2057910285 creator A5039948500 @default.
• W2057910285 creator A5044889423 @default.
• W2057910285 date "2006-03-01" @default.
• W2057910285 modified "2023-10-05" @default.
• W2057910285 title "The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats" @default.
• W2057910285 cites W1966419887 @default.
• W2057910285 cites W1967172766 @default.
• W2057910285 cites W1968985689 @default.
• W2057910285 cites W1982065972 @default.
• W2057910285 cites W1990781293 @default.
• W2057910285 cites W2005612135 @default.
• W2057910285 cites W2007671598 @default.
• W2057910285 cites W2007880055 @default.
• W2057910285 cites W2012503408 @default.
• W2057910285 cites W2059052527 @default.
• W2057910285 cites W2060189918 @default.
• W2057910285 cites W2062607383 @default.
• W2057910285 cites W2074098680 @default.
• W2057910285 cites W2087045253 @default.
• W2057910285 cites W2096281503 @default.
• W2057910285 cites W2097179438 @default.
• W2057910285 cites W2109964559 @default.
• W2057910285 cites W2141253144 @default.
• W2057910285 cites W2149332876 @default.
• W2057910285 cites W2162278141 @default.
• W2057910285 cites W2169537677 @default.
• W2057910285 cites W2279887543 @default.
• W2057910285 doi "https://doi.org/10.1016/j.ejphar.2006.01.063" @default.
• W2057910285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16516190" @default.
• W2057910285 hasPublicationYear "2006" @default.
• W2057910285 type Work @default.
• W2057910285 sameAs 2057910285 @default.
• W2057910285 citedByCount "7" @default.
• W2057910285 countsByYear W20579102852013 @default.
• W2057910285 countsByYear W20579102852014 @default.
• W2057910285 countsByYear W20579102852017 @default.
• W2057910285 countsByYear W20579102852022 @default.
• W2057910285 crossrefType "journal-article" @default.
• W2057910285 hasAuthorship W2057910285A5002206863 @default.
• W2057910285 hasAuthorship W2057910285A5003379401 @default.
• W2057910285 hasAuthorship W2057910285A5010069897 @default.
• W2057910285 hasAuthorship W2057910285A5039948500 @default.
• W2057910285 hasAuthorship W2057910285A5044889423 @default.
• W2057910285 hasBestOaLocation W20579102851 @default.
• W2057910285 hasConcept C126322002 @default.
• W2057910285 hasConcept C134018914 @default.
• W2057910285 hasConcept C181199279 @default.
• W2057910285 hasConcept C185592680 @default.
• W2057910285 hasConcept C195794163 @default.
• W2057910285 hasConcept C2775910092 @default.
• W2057910285 hasConcept C2776108454 @default.
• W2057910285 hasConcept C2776992346 @default.
• W2057910285 hasConcept C2777952589 @default.
• W2057910285 hasConcept C2778163477 @default.
• W2057910285 hasConcept C2779280383 @default.
• W2057910285 hasConcept C2779610285 @default.
• W2057910285 hasConcept C2780940807 @default.
• W2057910285 hasConcept C2780972559 @default.
• W2057910285 hasConcept C519581460 @default.
• W2057910285 hasConcept C55493867 @default.
• W2057910285 hasConcept C555293320 @default.
• W2057910285 hasConcept C71924100 @default.
• W2057910285 hasConcept C84393581 @default.
• W2057910285 hasConcept C98274493 @default.
• W2057910285 hasConceptScore W2057910285C126322002 @default.
• W2057910285 hasConceptScore W2057910285C134018914 @default.
• W2057910285 hasConceptScore W2057910285C181199279 @default.
• W2057910285 hasConceptScore W2057910285C185592680 @default.
• W2057910285 hasConceptScore W2057910285C195794163 @default.
• W2057910285 hasConceptScore W2057910285C2775910092 @default.
• W2057910285 hasConceptScore W2057910285C2776108454 @default.
• W2057910285 hasConceptScore W2057910285C2776992346 @default.
• W2057910285 hasConceptScore W2057910285C2777952589 @default.
• W2057910285 hasConceptScore W2057910285C2778163477 @default.
• W2057910285 hasConceptScore W2057910285C2779280383 @default.
• W2057910285 hasConceptScore W2057910285C2779610285 @default.
• W2057910285 hasConceptScore W2057910285C2780940807 @default.
• W2057910285 hasConceptScore W2057910285C2780972559 @default.
• W2057910285 hasConceptScore W2057910285C519581460 @default.
• W2057910285 hasConceptScore W2057910285C55493867 @default.
• W2057910285 hasConceptScore W2057910285C555293320 @default.
• W2057910285 hasConceptScore W2057910285C71924100 @default.
• W2057910285 hasConceptScore W2057910285C84393581 @default.
• W2057910285 hasConceptScore W2057910285C98274493 @default.
• W2057910285 hasIssue "1-3" @default.
• W2057910285 hasLocation W20579102851 @default.
• W2057910285 hasLocation W20579102852 @default.
• W2057910285 hasOpenAccess W2057910285 @default.
• W2057910285 hasPrimaryLocation W20579102851 @default.
• W2057910285 hasRelatedWork W130546840 @default.
• W2057910285 hasRelatedWork W153207093 @default.
• W2057910285 hasRelatedWork W1995071802 @default.
• W2057910285 hasRelatedWork W2006842018 @default.

• next